Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
NCT06322563
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Advanced/Metastatic Colorectal Cancer
Interventions
DRUG:
LTC004+regorafenib
Sponsor
Tianjin Medical University Cancer Institute and Hospital